Company Search:
Advanced Search
Sponsored Links
Acorda Therapeutics, Inc. Company Snapshot
Acorda Therapeutics, Inc. operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Acorda Therapeutics with three other companies in this sector in the United States: Seattle Genetics, Inc. (2015 sales of $336.80 million of which 100% was Monoclonal Drugs), PDL Biopharma, Inc. ($590.45 million of which 100% was Antibody Products), and BIO-TECHNE Corp ($452.25 million of which 72% was Biotechnology).

Sales Analysis. During the year ended December of 2015, sales at Acorda Therapeutics were $492.66 million. This is an increase of 22.7% versus 2014, when the company's sales were $401.48 million. This was the fifth consecutive year of sales increases at Acorda Therapeutics (and since 2010, sales have increased a total of 158%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Acorda Therapeutics, Inc.
  Stock Performance Chart for Acorda Therapeutics, Inc.
  Stock Data: Recent Stock Performance:
  Current Price (1/13/2017): 21.40
(Figures in U.S. Dollars)
1 Week 1.2%   13 Weeks 6.5%  
4 Weeks 9.0%   52 Weeks -46.4%  
Acorda Therapeutics, Inc. Key Data:
  Ticker: ACOR Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2015 Sales 492,660,000
(Year Ending Jan 2016).
Employees: 535
  Currency: U.S. Dollars Market Cap: 986,846,148
  Fiscal Yr Ends: December Shares Outstanding: 46,114,306
  Share Type: Common Closely Held Shares: 799,023
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.